Filing Details
- Accession Number:
- 0001415889-22-007059
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-29 20:09:32
- Reporting Period:
- 2022-06-27
- Accepted Time:
- 2022-06-29 20:09:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1479419 | Kala Pharmaceuticals Inc. | KALA | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1415537 | T Mark Iwicki | C/O Kala Pharmaceuticals, Inc. 1167 Massachusetts Avenue Arlington MA 02476 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-06-27 | 7,975 | $0.37 | 251,183 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This sale was made pursuant to a 10b5-1 trading plan to cover tax withholding obligations in connection with the vesting and settlement of the reporting person's restricted stock units granted on June 25, 2020.
- Includes 139,819 unvested RSUs.
Billionaire Hedge Funds
